Notice2026-03060
Citric Acid and Certain Citrate Salts From Canada and India: Initiation of Countervailing Duty Investigations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 17, 2026
Issuing agencies
Commerce DepartmentInternational Trade Administration
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 31 (Tuesday, February 17, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 31 (Tuesday, February 17, 2026)]
[Notices]
[Pages 7257-7261]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-03060]
[[Page 7257]]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
International Trade Administration
[C-122-878, C-533-947]
Citric Acid and Certain Citrate Salts From Canada and India:
Initiation of Countervailing Duty Investigations
AGENCY: Enforcement and Compliance, International Trade Administration,
Department of Commerce.
DATES: Applicable February 10, 2026.
FOR FURTHER INFORMATION CONTACT: Natasia Byrd at (202) 482-1240 and
Harrison Tanchuck at (202) 482-7421 (Canada) and Erin Howard at (202)
482-3453 (India), AD/CVD Operations, Enforcement and Compliance,
International Trade Administration, U.S. Department of Commerce, 1401
Constitution Avenue NW, Washington, DC 20230.
SUPPLEMENTARY INFORMATION:
The Petitions
On January 21, 2026, the U.S. Department of Commerce (Commerce)
received countervailing duty (CVD) petitions concerning imports of
citric acid and certain citrate salts from Canada and India filed in
proper form on behalf of Archer-Daniels-Midland Company, Cargill
Incorporated, and Primary Products Ingredients Americas LLC
(collectively, the petitioners), domestic producers of citric acid and
certain citrate salts.\1\ The CVD Petitions were accompanied by
antidumping duty (AD) petitions concerning imports of citric acid and
certain citrate salts from Canada and India.\2\
---------------------------------------------------------------------------
\1\ See Petitioners' Letter, ``Petitions for the Imposition of
Antidumping and Countervailing Duties on Imports of Citric Acid and
Certain Citrate Salts from Canada and India,'' dated January 21,
2026 (Petitions).
\2\ Id.
---------------------------------------------------------------------------
Between January 26 and February 6, 2026, Commerce requested
supplemental information pertaining to certain aspects of the Petitions
in supplemental questionnaires.\3\ Between January 29 and February 9,
2026, the petitioners filed timely responses to these requests for
additional information.\4\
---------------------------------------------------------------------------
\3\ See Commerce's Letters, ``Supplemental Questions,'' dated
January 26, 2026 (General Issues Supplemental Questionnaire); see
also First Country-Specific CVD Supplemental Questionnaires: Canada
CVD Supplemental and India CVD Supplemental, dated January 26, 2026;
see also Memorandum ``Phone Call with Counsel to the Petitioners,''
dated February 6, 2026.
\4\ See Petitioners' Letters, ``Response to Supplemental
Questions,'' dated January 29, 2026 (General Issues Supplement); see
also Country-Specific CVD Supplemental Responses: Canada CVD
Supplement and India CVD Supplement, dated January 30 and February
2, 2026; see also ``Petitioners' Corrected Representative
Certification,'' dated February 9, 2026.
---------------------------------------------------------------------------
In accordance with section 702(b)(1) of the Tariff Act of 1930, as
amended (the Act), the petitioners allege that the Government of Canada
(GOC) and Government of India (GOI), are providing countervailable
subsidies, within the meaning of sections 701 and 771(5) of the Act, to
producers of citric acid and certain citrate salts in Canada and India
and that such imports are materially injuring, or threatening material
injury to, the domestic industry producing citric acid and certain
citrate salts in the United States. Consistent with section 702(b)(1)
of the Act and 19 CFR 351.202(b), for those alleged programs on which
we are initiating CVD investigations, the Petitions were accompanied by
information reasonably available to the petitioners supporting their
allegations.
Commerce finds that the petitioners filed the Petitions on behalf
of the domestic industry, because the petitioners are interested
parties, as defined in section 771(9)(C) of the Act. Commerce also
finds that the petitioners demonstrated sufficient industry support
with respect to the initiation of the requested CVD investigations.\5\
---------------------------------------------------------------------------
\5\ See section on ``Determination of Industry Support for the
Petitions,'' infra.
---------------------------------------------------------------------------
Periods of Investigation (POI)
Because the Petitions were filed on January 21, 2026, the POI for
the Canada and India CVD investigations is January 1, 2025, through
December 31, 2025.\6\
---------------------------------------------------------------------------
\6\ See 19 CFR 351.204(b)(2).
---------------------------------------------------------------------------
Scope of the Investigations
The products covered by these investigations are citric acid and
certain citrate salts from Canada and India. For a full description of
the scope of these investigations, see the appendix to this notice.
Comments on the Scope of the Investigations
On January 26, 2026, Commerce requested information and
clarification from the petitioners regarding the proposed scope to
ensure that the scope language in the Petitions is an accurate
reflection of the products for which the domestic industry is seeking
relief.\7\ On January 29, 2026, the petitioners provided clarifications
and revised the scope.\8\ The description of merchandise covered by
these investigations, as described in the appendix to this notice,
reflects these clarifications.
---------------------------------------------------------------------------
\7\ See General Issues Supplemental Questionnaire.
\8\ See General Issues Supplement at 2-3 and Exhibit I-S4.
---------------------------------------------------------------------------
As discussed in the Preamble to Commerce's regulations, we are
setting aside a period for interested parties to raise issues regarding
product coverage (i.e., scope).\9\ Commerce will consider all scope
comments received from interested parties and, if necessary, will
consult with interested parties prior to the issuance of the
preliminary determinations. If scope comments include factual
information, all such factual information should be limited to public
information.\10\ Commerce requests that interested parties provide at
the beginning of their scope comments a public executive summary for
each comment or issue raised in their submission. Commerce further
requests that interested parties limit their public executive summary
of each comment or issue to no more than 450 words, not including
citations. Commerce intends to use the public executive summaries as
the basis of the comment summaries included in the analysis of scope
comments. To facilitate preparation of its questionnaires, Commerce
requests that scope comments be submitted by 5:00 p.m. Eastern Time
(ET) on March 2, 2026, which is 20 calendar days from the signature
date of this notice. Any rebuttal comments, which may include factual
information, and should also be limited to public information, must be
filed by 5:00 p.m. ET on March 12, 2026, which is 10 calendar days from
the initial comment deadline.
---------------------------------------------------------------------------
\9\ See Antidumping Duties; Countervailing Duties, Final Rule,
62 FR 27296, 27323 (May 19, 1997) (Preamble); see also 19 CFR
351.312.
\10\ See 19 CFR 351.102(b)(21) (defining ``factual
information'').
---------------------------------------------------------------------------
Commerce requests that any factual information that parties
consider relevant to the scope of these investigations be submitted
during that period. However, if a party subsequently finds that
additional factual information pertaining to the scope of the
investigations may be relevant, the party must contact Commerce and
request permission to submit the additional information. All scope
comments must be filed simultaneously on the records of the concurrent
AD and CVD investigations.
Filing Requirements
All submissions to Commerce must be filed electronically via
Enforcement and Compliance's Antidumping Duty and Countervailing Duty
Centralized Electronic Service System (ACCESS),
[[Page 7258]]
unless an exception applies.\11\ An electronically filed document must
be received successfully in its entirety by the time and date it is
due.
---------------------------------------------------------------------------
\11\ See Antidumping and Countervailing Duty Proceedings:
Electronic Filing Procedures; Administrative Protective Order
Procedures, 76 FR 39263 (July 6, 2011); see also Enforcement and
Compliance; Change of Electronic Filing System Name, 79 FR 69046
(November 20, 2014), for details of Commerce's electronic filing
requirements, effective August 5, 2011. Information on using ACCESS
can be found at <a href="https://access.trade.gov/help.aspx">https://access.trade.gov/help.aspx</a> and a handbook
can be found at <a href="https://access.trade.gov/help/Handbook_on_Electronic_Filing_Procedures.pdf">https://access.trade.gov/help/Handbook_on_Electronic_Filing_Procedures.pdf</a>.
---------------------------------------------------------------------------
Consultations
Pursuant to sections 702(b)(4)(A)(i) and (ii) of the Act, Commerce
notified the GOC and GOI of the receipt of the Petitions and provided
an opportunity for consultations with respect to the Petitions.\12\
Commerce held consultations with the GOC on February 4, 2026, and with
the GOI on February 6, 2026.\13\
---------------------------------------------------------------------------
\12\ See Commerce's Letters, ``Invitation for Consultations to
Discuss the Countervailing Duty Petition,'' dated January 21, 2026.
\13\ See Memorandum, ``Consultations with the Government of
Canada,'' dated February 5, 2026; see also GOC's Letter,
``Government of Canada's Consultations Materials,'' dated February
5, 2026; Memorandum, ``Consultations with the Government of India,''
dated February 6, 2026; and GOI's Letter, ``GOI's Pre-Initiation
Comments and Consultation Note (C-533-947), dated February 10, 2026.
---------------------------------------------------------------------------
Additionally, given the nature of certain subsidy programs alleged
in the India CVD Petition, on January 21, 2026, Commerce issued a
letter to the Government of the People's Republic of China (China),
providing the Government of China with the opportunity to meet with
Commerce officials.\14\ The Government of China did not request to meet
with Commerce officials, but filed written comments.\15\
---------------------------------------------------------------------------
\14\ See Commerce's Letter, ``Alleged Transnational Subsidy
Programs'' dated January 21, 2026.
\15\ See Government of China's Letter, ``Comments on CVD
Petition on Citric Acid and Certain Citrate Salts from India:
Alleged Transnational Subsidy Programs (C-533-947),'' dated February
4, 2026.
---------------------------------------------------------------------------
Determination of Industry Support for the Petitions
Section 702(b)(1) of the Act requires that a petition be filed on
behalf of the domestic industry. Section 702(c)(4)(A) of the Act
provides that the petition meet this requirement if the domestic
producers or workers who support the petition account for: (i) at least
25 percent of the total production of the domestic like product; and
(ii) more than 50 percent of the production of the domestic like
product produced by that portion of the industry expressing support
for, or opposition to, the petition. Moreover, section 702(c)(4)(D) of
the Act provides that, if the petition does not establish support of
domestic producers or workers accounting for more than 50 percent of
the total production of the domestic like product, Commerce shall: (i)
poll the industry or rely on other information in order to determine if
there is support for the petition, as required by subparagraph (A); or
(ii) determine industry support using a statistically valid sampling
method to poll the ``industry.''
Section 771(4)(A) of the Act defines the ``industry'' as the
producers as a whole of a domestic like product. Thus, to determine
whether a petition has the requisite industry support, the statute
directs Commerce to look to producers and workers who produce the
domestic like product. The U.S. International Trade Commission (ITC),
which is responsible for determining whether ``the domestic industry''
has been injured, must also determine what constitutes a domestic like
product in order to define the industry. While both Commerce and the
ITC apply the same statutory definition regarding the domestic like
product,\16\ they do so for different purposes and pursuant to a
separate and distinct authority. In addition, Commerce's determination
is subject to limitations of time and information. Although this may
result in different definitions of the like product, such differences
do not render the decision of either agency contrary to law.\17\
---------------------------------------------------------------------------
\16\ See section 771(10) of the Act.
\17\ See USEC, Inc. v. United States, 132 F.Supp.2d 1, 8 (CIT
2001) (citing Algoma Steel Corp., Ltd. v. United States, 688 F.Supp.
639, 644 (CIT 1988), aff'd Algoma Steel Corp., Ltd. v. United
States, 865 F.2d 240 (Fed. Cir. 1989)).
---------------------------------------------------------------------------
Section 771(10) of the Act defines the domestic like product as ``a
product which is like, or in the absence of like, most similar in
characteristics and uses with, the article subject to an investigation
under this title.'' Thus, the reference point from which the domestic
like product analysis begins is ``the article subject to an
investigation'' (i.e., the class or kind of merchandise to be
investigated, which normally will be the scope as defined in the
petition).
With regard to the domestic like product, the petitioners do not
offer a definition of the domestic like product distinct from the scope
of the investigations.\18\ Based on our analysis of the information
submitted on the record, we have determined that citric acid and
certain citrate salts, as defined in the scope, constitute a single
domestic like product, and we have analyzed industry support in terms
of that domestic like product.\19\
---------------------------------------------------------------------------
\18\ For a discussion of the domestic like product analysis as
applied to these cases and information regarding industry support,
see Checklists, ``Countervailing Duty Investigation Initiation
Checklists: Citric Acid and Certain Citrate Salts from the Canada
and India,'' dated concurrently with, and hereby adopted by, this
notice (Country-Specific CVD Initiation Checklists), at Attachment
II, Analysis of Industry Support for the Antidumping and
Countervailing Duty Petitions Covering Citric Acid and Certain
Citrate Salts from Canada and India (Attachment II). These
checklists are on file electronically via ACCESS.
\19\ For further discussion, see Attachment II of the Country-
Specific CVD Initiation Checklists.
---------------------------------------------------------------------------
In determining whether the petitioners have standing under section
702(c)(4)(A) of the Act, we considered the industry support data
contained in the Petitions with reference to the domestic like product
as defined in the ``Scope of the Investigations,'' in the appendix to
this notice. To establish industry support, the petitioners provided
their own production of the domestic like product in 2025.\20\ The
petitioners identified themselves as the only producers of citric acid
and certain citrate salts in the United States; therefore, the
Petitions are supported by 100 percent of the U.S. industry.\21\ We
relied on data provided by the petitioners for purposes of measuring
industry support.\22\
---------------------------------------------------------------------------
\20\ Id.
\21\ Id.
\22\ Id.
---------------------------------------------------------------------------
Our review of the data provided in the Petitions, the General
Issues Supplement, and other information readily available to Commerce
indicates that the petitioners have established industry support for
the Petitions.\23\ First, the Petitions established support from
domestic producers (or workers) accounting for more than 50 percent of
the total production of the domestic like product and, as such,
Commerce is not required to take further action in order to evaluate
industry support (e.g., polling).\24\ Second, the domestic producers
(or workers) have met the statutory criteria for industry support under
section 702(c)(4)(A)(i) of the Act because the domestic producers (or
workers) who support the Petitions account for at least 25 percent of
the total production of the domestic like product.\25\ Finally, the
domestic producers (or workers) have met the statutory criteria for
industry support under section 702(c)(4)(A)(ii) of the Act because the
domestic producers (or workers) who support the Petitions account for
more than 50 percent of the production of the domestic like product
produced by that portion of the industry expressing support for, or
opposition to,
[[Page 7259]]
the Petitions.\26\ Accordingly, Commerce determines that the Petitions
were filed on behalf of the domestic industry within the meaning of
section 702(b)(1) of the Act.\27\
---------------------------------------------------------------------------
\23\ Id.
\24\ Id.; see also section 702(c)(4)(D) of the Act.
\25\ See Attachment II of the Country-Specific CVD Initiation
Checklists.
\26\ Id.
\27\ Id.
---------------------------------------------------------------------------
Injury Test
Because Canada and India are ``Subsidies Agreement Countries''
within the meaning of section 701(b) of the Act, section 701(a)(2) of
the Act applies to these investigations. Accordingly, the ITC must
determine whether imports of the subject merchandise from Canada and/or
India materially injure, or threaten material injury to, a U.S.
industry.
Allegations and Evidence of Material Injury and Causation
The petitioners allege that imports of the subject merchandise are
benefiting from countervailable subsidies and that such imports are
causing, or threaten to cause, material injury to the U.S. industry
producing the domestic like product. In addition, the petitioners
allege that subject imports from Canada and India individually exceed
the negligibility threshold provided for under section 771(24)(A) of
the Act.\28\
---------------------------------------------------------------------------
\28\ For further discussion, see Country-Specific CVD Initiation
Checklists at Attachment III, Analysis of Allegations and Evidence
of Material Injury and Causation for the Antidumping and
Countervailing Duty Petitions Covering Citric Acid and Certain
Citrate Salts from Canada and India.
---------------------------------------------------------------------------
The petitioners contend that the industry's injured condition is
illustrated by a significant increase in the volume of subject imports;
increased market share of subject imports; underselling and price
depression and/or suppression; lost sales and revenues; declines in
production, capacity utilization, and U.S shipments; and negative
impact on financial performance.\29\ We assessed the allegations and
supporting evidence regarding material injury, threat of material
injury, causation, cumulation, as well as negligibility, and we have
determined that these allegations are properly supported by adequate
evidence, and meet the statutory requirements for initiation.\30\
---------------------------------------------------------------------------
\29\ Id.
\30\ Id.
---------------------------------------------------------------------------
Initiation of CVD Investigations
Based upon the examination of the Petitions and supplemental
responses, we find that they meet the requirements of section 702 of
the Act. Therefore, we are initiating CVD investigations to determine
whether imports of citric acid and certain citrate salts from Canada
and India benefit from countervailable subsidies conferred by the GOC
and GOI, respectively. In accordance with section 703(b)(1) of the Act
and 19 CFR 351.205(b)(1), unless postponed, we will make our
preliminary determinations no later than 65 days after the date of this
initiation.
Canada
Based on our review of the Petitions, we find that there is
sufficient information to initiate a CVD investigation on 20 of the 21
programs alleged by the petitioners. For a full discussion of the basis
for our initiation decisions on each program, see the Canada CVD
Initiation Checklist. A public version of the initiation checklist for
this investigation is available on ACCESS.
India
Based on our review of the Petitions, we find that there is
sufficient information to initiate a CVD investigation on all programs
alleged by the petitioners. For a full discussion of the basis for our
decision to initiate on each program, see the India CVD Initiation
Checklist. A public version of the initiation checklist for this
investigation is available on ACCESS.
Respondent Selection
Canada
In the Petitioners, the petitioners identified one company (i.e.,
Jungbunzlauer Canada Inc. (JBL)) in Canada as a producer/exporter of
citric acid and certain citrate salts and provided independent third-
party information as support.\31\ We currently know of no additional
producers/exporters of citric acid and certain citrate salts from
Canada.
---------------------------------------------------------------------------
\31\ Petitions at Volume I (Exhibit I-2); see also General
Issues Supplement at 1.
---------------------------------------------------------------------------
Accordingly, Commerce intends to individually examine the only
producer/exporter in the investigation from Canada (i.e., JBL). We
invite interested parties to comment on this issue. Such comments may
include factual information within the meaning of 19 CFR
351.102(b)(21). Parties wishing to comment must do so within three
business days of the publication of this notice in the Federal
Register. Comments must be filed electronically using ACCESS. An
electronically filed document must be received successfully in its
entirety via ACCESS by 5:00 p.m. ET on the specified deadline. Because
we intend to examine the only known producer/exporter in Canada, if no
comments are received or if comments received further support the
existence of this sole producer/exporter in the respective countries,
we do not intend to conduct respondent selection and will proceed to
issuing the initial questionnaire to the only company identified (i.e.,
JBL). However, if comments are received which create a need for a
respondent selection process, we intend to finalize our decisions
regarding the respondent selection within 20 days of publication of
this notice.
India
In the Petitions, the petitioners identified 19 companies in India
as producers and/or exporters of citric acid and certain citrate
salts.\32\ Following standard practice in CVD investigations, in the
event Commerce determines that the number of companies is large, and it
cannot individually examine each company based upon Commerce's
resources, where appropriate, Commerce intends to select mandatory
respondents based on U.S. Customs and Border Protection (CBP) data for
imports under the appropriate Harmonized tariff Schedule of the United
States (HTSUS) subheading(s) listed in the ``Scope of the
Investigations,'' in the appendix.
---------------------------------------------------------------------------
\32\ See Petitions at Volume I (page 21 and Exhibit I-11).
---------------------------------------------------------------------------
On February 10, 2026, Commerce released CBP data on imports of
citric acid and certain citrate salts from India under administrative
protective order (APO) to all parties with access to information
protected by APO and indicated that interested parties wishing to
comment on CBP data and/or respondent selection must do so within three
days of the publication date of the notice of initiation of these
investigations.\33\ Comments must be filed electronically using ACCESS.
An electronically filed document must be received successfully in its
entirety via ACCESS by 5:00 p.m. ET on the specified deadline. Commerce
will not accept rebuttal comments regarding the CBP data or respondent
selection.
---------------------------------------------------------------------------
\33\ See Memorandum, ``Release of U.S. Customs and Border
Protection Entry Data,'' dated February 10, 2026.
---------------------------------------------------------------------------
Interested parties must submit applications for disclosure under
APO in accordance with 19 CFR 351.305(b). Instructions for filing such
applications may be found on Commerce's website at <a href="https://www.trade.gov/administrative-protective-orders">https://www.trade.gov/administrative-protective-orders</a>.
Distribution of Copies of the Petitions
In accordance with section 702(b)(4)(A) of the Act and 19 CFR
351.202(f), a copy of the public version of the Petitions has been
provided to the GOC and GOI via ACCESS. To the
[[Page 7260]]
extent practicable, we will attempt to provide a copy of the public
version of the Petitions to each exporter named in the Petitions, as
provided under 19 CFR 351.203(c)(2).
ITC Notification
Commerce will notify the ITC of its initiation, as required by
section 702(d) of the Act.
Preliminary Determinations by the ITC
The ITC will preliminarily determine, within 45 days after the date
on which the Petitions were filed, whether there is a reasonable
indication that imports of citric acid and certain citrate salts from
Canada and/or India are materially injuring, or threatening material
injury to, a U.S. industry.\34\ A negative ITC determination for either
country will result in the investigation being terminated with respect
to that country.\35\ Otherwise, these CVD investigations will proceed
according to statutory and regulatory time limits.
---------------------------------------------------------------------------
\34\ See section 703(a)(1) of the Act.
\35\ Id.
---------------------------------------------------------------------------
Submission of Factual Information
Factual information is defined in 19 CFR 351.102(b)(21) as: (i)
evidence submitted in response to questionnaires; (ii) evidence
submitted in support of allegations; (iii) publicly available
information to value factors of production under 19 CFR 351.408(c) or
to measure the adequacy of remuneration under 19 CFR 351.511(a)(2);
(iv) evidence placed on the record by Commerce; and (v) evidence other
than factual information described in (i)-(iv). Section 351.301(b) of
Commerce's regulations requires any party, when submitting factual
information, to specify under which subsection of 19 CFR 351.102(b)(21)
the information is being submitted \36\ and, if the information is
submitted to rebut, clarify, or correct factual information already on
the record, to provide an explanation identifying the information
already on the record that the factual information seeks to rebut,
clarify, or correct.\37\ Time limits for the submission of factual
information are addressed in 19 CFR 351.301, which provides specific
time limits based on the type of factual information being submitted.
Interested parties should review the regulations prior to submitting
factual information in these investigations.
---------------------------------------------------------------------------
\36\ See 19 CFR 351.301(b); see also Extension of Time Limits;
Final Rule, 78 FR 57790 (September 20, 2013) (Time Limits Final
Rule), available at <a href="https://www.gpo.gov/fdsys/pkg/FR-2013-09-20/html/2013-22853.htm">https://www.gpo.gov/fdsys/pkg/FR-2013-09-20/html/2013-22853.htm</a>.
\37\ See 19 CFR 351.301(b)(2).
---------------------------------------------------------------------------
Extensions of Time Limits
Parties may request an extension of time limits before the
expiration of a time limit established under 19 CFR 351.301, or as
otherwise specified by Commerce. In general, an extension request will
be considered untimely if it is filed after the expiration of the time
limit established under 19 CFR 351.301, or as otherwise specified by
Commerce.\38\ For submissions that are due from multiple parties
simultaneously, an extension request will be considered untimely if it
is filed after 10:00 a.m. ET on the due date. Under certain
circumstances, Commerce may elect to specify a different time limit by
which extension requests will be considered untimely for submissions
which are due from multiple parties simultaneously. In such a case, we
will inform parties in a letter or memorandum of the deadline
(including a specified time) by which extension requests must be filed
to be considered timely. An extension request must be made in a
separate, standalone submission; under limited circumstances we will
grant untimely filed requests for the extension of time limits, where
we determine, based on 19 CFR 351.302, that extraordinary circumstances
exist. Parties should review Commerce's regulations concerning the
extension of time limits and the Time Limits Final Rule prior to
submitting factual information in these investigations.\39\
---------------------------------------------------------------------------
\38\ See 19 CFR 351.302.
\39\ See 19 CFR 351.301; see also Time Limits Final Rule, 78 FR
at 57790.
---------------------------------------------------------------------------
Certification Requirements
Any party submitting factual information in an AD or CVD proceeding
must certify to the accuracy and completeness of that information.\40\
Parties must use the certification formats provided in 19 CFR
351.303(g).\41\ Commerce intends to reject factual submissions if the
submitting party does not comply with the applicable certification
requirements.
---------------------------------------------------------------------------
\40\ See section 782(b) of the Act.
\41\ See Certification of Factual Information to Import
Administration During Antidumping and Countervailing Duty
Proceedings, 78 FR 42678 (July 17, 2013) (Final Rule); see also
frequently asked questions regarding the Final Rule, available at
<a href="https://enforcement.trade.gov/tlei/notices/factual_info_final_rule_FAQ_07172013.pdf">https://enforcement.trade.gov/tlei/notices/factual_info_final_rule_FAQ_07172013.pdf</a>.
---------------------------------------------------------------------------
Notification to Interested Parties
Interested parties must submit applications for disclosure under
APO in accordance with 19 CFR 351.305. Parties wishing to participate
in these investigations should ensure that they meet the requirements
of 19 CFR 351.103(d) (e.g., by filing the required letters of
appearance). Note that Commerce has amended certain of its requirements
pertaining to the service of documents in 19 CFR 351.303(f).\42\
---------------------------------------------------------------------------
\42\ See Administrative Protective Order, Service, and Other
Procedures in Antidumping and Countervailing Duty Proceedings, 88 FR
67069 (September 29, 2023).
---------------------------------------------------------------------------
This notice is issued and published pursuant to sections 702 and
777(i) of the Act, and 19 CFR 351.203(c).
Dated: February 10, 2026.
Christopher Abbott,
Deputy Assistant Secretary for Policy and Negotiations, performing the
non-exclusive functions and duties of the Assistant Secretary for
Enforcement and Compliance.
Appendix
Scope of the Investigations
The merchandise covered by these investigations includes all
grades and granulation sizes of citric acid, sodium citrate, and
potassium citrate in their unblended forms, whether dry or in
solution, and regardless of packaging type. The scope also includes
blends of citric acid, sodium citrate, and potassium citrate, as
well as blends with other ingredients, such as sugar, where the
unblended form(s) of citric acid, sodium citrate, and potassium
citrate constitute 40 percent or more, by weight, of the blend.
The scope also includes all forms of crude calcium citrate,
including dicalcium citrate monohydrate, and tricalcium citrate
tetrahydrate, which are intermediate products in the production of
citric acid, sodium citrate, and potassium citrate. The scope
includes the hydrous and anhydrous forms of citric acid, the
dihydrate and anhydrous forms of sodium citrate, otherwise known as
citric acid sodium salt, and the monohydrate and monopotassium forms
of potassium citrate. Sodium citrate also includes both trisodium
citrate and monosodium citrate which are also known as citric acid
trisodium salt and citric acid monosodium salt, respectively.
The scope includes merchandise matching the above description
that has been processed in a third country, including by
commingling, diluting, introducing or removing additives, or
performing any other processing that would not otherwise remove the
merchandise from the scope of the investigations if performed in the
subject country. The scope also includes merchandise matching the
above description that is commingled or blended with citric acid,
sodium citrate, and potassium citrate from sources not subject to
these investigations. Only the subject component of such commingled
products is covered by the scope of these investigations.
The scope does not include calcium citrate that satisfies the
standards set forth in the United States Pharmacopeia and has been
mixed with a functional excipient, such as
[[Page 7261]]
dextrose or starch, where the excipient constitutes at least two
percent, by weight, of the product.
Citric acid and sodium citrate are classifiable under
2918.14.0000 and 2918.15.1000 of the Harmonized Tariff Schedule of
the United States (HTSUS), respectively. Potassium citrate and crude
calcium citrate are classifiable under 2918.15.5000 and, if included
in a mixture or blend, 3824.99.9397 of the HTSUS. Blends that
include citric acid, sodium citrate, and potassium citrate are
classifiable under 3824.99.9397 of the HTSUS. Although the HTSUS
subheadings are provided for convenience and customs purposes, the
written description of the merchandise is dispositive.
[FR Doc. 2026-03060 Filed 2-13-26; 8:45 am]
BILLING CODE 3510-DS-P
</pre></body>
</html>Indexed from Federal Register on February 17, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.